194 related articles for article (PubMed ID: 38415658)
1. Transdermal administration of farnesol-ethosomes enhances the treatment of cutaneous candidiasis induced by
Shen T; Tian B; Liu W; Yang X; Sheng Q; Li M; Wang H; Wang X; Zhou H; Han Y; Ding C; Sai S
Microbiol Spectr; 2024 Apr; 12(4):e0424723. PubMed ID: 38415658
[TBL] [Abstract][Full Text] [Related]
2. The in vitro and in vivo efficacy of fluconazole in combination with farnesol against Candida albicans isolates using a murine vulvovaginitis model.
Bozó A; Domán M; Majoros L; Kardos G; Varga I; Kovács R
J Microbiol; 2016 Nov; 54(11):753-760. PubMed ID: 27796932
[TBL] [Abstract][Full Text] [Related]
3. Comparative transcriptional analysis of
Jakab Á; Kovács F; Balla N; Nagy-Köteles C; Ragyák Á; Nagy F; Borman AM; Majoros L; Kovács R
Microbiol Spectr; 2024 Apr; 12(4):e0227823. PubMed ID: 38440972
[No Abstract] [Full Text] [Related]
4. Development of Anti-Virulence Approaches for Candidiasis via a Novel Series of Small-Molecule Inhibitors of
Romo JA; Pierce CG; Chaturvedi AK; Lazzell AL; McHardy SF; Saville SP; Lopez-Ribot JL
mBio; 2017 Dec; 8(6):. PubMed ID: 29208749
[No Abstract] [Full Text] [Related]
5. [Investigation of the Effect of Farnesol on Biofilm Formation by Candida albicans and Candida parapsilosis Complex Isolates].
Erdal B; Baylan B; Batar B; Öztürk A; Topçu B
Mikrobiyol Bul; 2024 Jan; 58(1):49-62. PubMed ID: 38263940
[TBL] [Abstract][Full Text] [Related]
6. In vitro interactions between farnesol and fluconazole, amphotericin B or micafungin against Candida albicans biofilms.
Katragkou A; McCarthy M; Alexander EL; Antachopoulos C; Meletiadis J; Jabra-Rizk MA; Petraitis V; Roilides E; Walsh TJ
J Antimicrob Chemother; 2015 Feb; 70(2):470-8. PubMed ID: 25288679
[TBL] [Abstract][Full Text] [Related]
7. Hexyl-Aminolevulinate Ethosomes: a Novel Antibiofilm Agent Targeting Zinc Homeostasis in Candida albicans.
Wang Y; Long W; Zhang F; Zhang M; Zeng K; Zhu X
Microbiol Spectr; 2022 Dec; 10(6):e0243822. PubMed ID: 36301105
[TBL] [Abstract][Full Text] [Related]
8. In vitro antibiofilm efficacy of farnesol against Candida species.
Yapıcı M; Gürsu BY; Dağ İ
Int Microbiol; 2021 May; 24(2):251-262. PubMed ID: 33604754
[TBL] [Abstract][Full Text] [Related]
9. Development, characterization, and in vitro-in vivo evaluation of polymeric nanoparticles containing miconazole and farnesol for treatment of vulvovaginal candidiasis.
Fernandes Costa A; Evangelista Araujo D; Santos Cabral M; Teles Brito I; Borges de Menezes Leite L; Pereira M; Correa Amaral A
Med Mycol; 2019 Jan; 57(1):52-62. PubMed ID: 29361177
[TBL] [Abstract][Full Text] [Related]
10. Chitosan nanoparticles encapsulating farnesol evaluated in vivo against Candida albicans.
Costa AF; da Silva JT; Martins JA; Rocha VL; de Menezes LB; Amaral AC
Braz J Microbiol; 2024 Mar; 55(1):143-154. PubMed ID: 37964169
[TBL] [Abstract][Full Text] [Related]
11. Effect of farnesol on a mouse model of systemic candidiasis, determined by use of a DPP3 knockout mutant of Candida albicans.
Navarathna DH; Hornby JM; Krishnan N; Parkhurst A; Duhamel GE; Nickerson KW
Infect Immun; 2007 Apr; 75(4):1609-18. PubMed ID: 17283095
[TBL] [Abstract][Full Text] [Related]
12. Utilization of an in vitro biofabricated 3D skin as a pathological model of cutaneous candidiasis.
Kitisin T; Muangkaew W; Ampawong S; Sukphopetch P
New Microbiol; 2020 Oct; 43(4):171-179. PubMed ID: 33021319
[TBL] [Abstract][Full Text] [Related]
13. Antifungal activity of farnesol incorporated in liposomes and associated with fluconazole.
Bezerra CF; de Alencar Júnior JG; de Lima Honorato R; Dos Santos ATL; Pereira da Silva JC; Gusmão da Silva T; Leal ALAB; Rocha JE; de Freitas TS; Tavares Vieira TA; Bezerra MCF; Sales DL; Kerntopf MR; de Araujo Delmondes G; Filho JMB; Peixoto LR; Pinheiro AP; Ribeiro-Filho J; Coutinho HDM; Morais-Braga MFB; Gonçalves da Silva T
Chem Phys Lipids; 2020 Nov; 233():104987. PubMed ID: 33058818
[TBL] [Abstract][Full Text] [Related]
14. The quorum-sensing molecule E,E-farnesol--its variable secretion and its impact on the growth and metabolism of Candida species.
Weber K; Schulz B; Ruhnke M
Yeast; 2010 Sep; 27(9):727-39. PubMed ID: 20641010
[TBL] [Abstract][Full Text] [Related]
15. Antibiofilm and antifungal activities of medium-chain fatty acids against Candida albicans via mimicking of the quorum-sensing molecule farnesol.
Lee JH; Kim YG; Khadke SK; Lee J
Microb Biotechnol; 2021 Jul; 14(4):1353-1366. PubMed ID: 33252828
[TBL] [Abstract][Full Text] [Related]
16. Pravastatin inhibits farnesol production in Candida albicans and improves survival in a mouse model of systemic candidiasis.
Tashiro M; Kimura S; Tateda K; Saga T; Ohno A; Ishii Y; Izumikawa K; Tashiro T; Kohno S; Yamaguchi K
Med Mycol; 2012 May; 50(4):353-60. PubMed ID: 21954955
[TBL] [Abstract][Full Text] [Related]
17. Modulation of Staphylococcus aureus Response to Antimicrobials by the Candida albicans Quorum Sensing Molecule Farnesol.
Kong EF; Tsui C; Kucharíková S; Van Dijck P; Jabra-Rizk MA
Antimicrob Agents Chemother; 2017 Dec; 61(12):. PubMed ID: 28893777
[TBL] [Abstract][Full Text] [Related]
18. The inhibition of trans-cinnamaldehyde on the virulence of Candida albicans via enhancing farnesol secretion with low potential for the development of resistance.
Ying L; Mingzhu S; Mingju Y; Ye X; Yuechen W; Ying C; Bing G; Hongchun L; Zuobin Z
Biochem Biophys Res Commun; 2019 Aug; 515(4):544-550. PubMed ID: 31176484
[TBL] [Abstract][Full Text] [Related]
19. Farnesol signalling in Candida albicans - more than just communication.
Polke M; Leonhardt I; Kurzai O; Jacobsen ID
Crit Rev Microbiol; 2018 Mar; 44(2):230-243. PubMed ID: 28609183
[TBL] [Abstract][Full Text] [Related]
20. Protective effects of farnesol against oral candidiasis in mice.
Hisajima T; Maruyama N; Tanabe Y; Ishibashi H; Yamada T; Makimura K; Nishiyama Y; Funakoshi K; Oshima H; Abe S
Microbiol Immunol; 2008 Jul; 52(7):327-33. PubMed ID: 18667031
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
